<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>12</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence of Toxoplasma gondii Infection among Healthy Blood Donors in Northeast of Iran</title>
    <FirstPage>554</FirstPage>
    <LastPage>562</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>SADOOGHIAN</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>MAHMOUDVAND</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>MOHAMMADI</LastName>
        <affiliation locale="en_US">Blood Transfusion Organization of Khorasan Razavi, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Naser</FirstName>
        <LastName>NAZARI SARCHESHMEH</LastName>
        <affiliation locale="en_US">Blood Transfusion Organization of Khorasan Razavi, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>TAVAKOLI KARESHK</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>KAMIABI</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Naser</FirstName>
        <LastName>ZIA-ALI</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: This cross-sectional investigation aimed to evaluate the prevalence of IgM and IgG anti- Toxoplasma gondii antibodies and the associated risk factors among healthy blood donors in Khorasan Razavi Province, northeast of Iran from Nov 2014 to May 2015.

Methods: Overall, 491 serum samples from apparently healthy blood donors referred the six biggest blood centers in Razavi Khorasan, Iran, were screened for IgG and IgM anti-T. gondii antibodies by enzyme-linked immunosorbent assay (ELISA). A structured questionnaire was used to obtain information on risk factors for T. gondii infection. Nested PCR was also used to detect DNA of T. gondii in the IgM-positive samples by using of B1 and RE (Repetitive Element) as marker for amplifying fragment size of 531 bp and 164 bp in PCR method.

Results: Totally, 200 (40.7%) samples were seropositive for anti-T. gondii antibodies; 184 (37.5%) donors tested seropositive for only IgG antibody, 8 (1.6%) tested seropositive for both IgM and IgG and 8 (1.6%) were positive for IgM antibody alone. Several risk factors significantly related to T. gondii seropositivity in the univariate analysis at P&lt;0.05 included age (P&lt;0.001), and raw/half-cocked meat consumption (P=0.015). T. gondii DNA was found in all sixteen IgM-positive samples.

Conclusion: T. gondii infection was present among healthy blood donors in northeast of Iran. Thus, it is suggested to design screening programs for preventing transfusion-transmitted toxoplasmosis.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/1929</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/1929/790</pdf_url>
  </Article>
</Articles>
